Chinese medicinal preparation for treating chronic cholecystitis

Abstract

The invention discloses a Chinese medicinal preparation for treating chronic cholecystitis, which is prepared from the following Chinese herbal medicines in part by weight: 25 to 45 parts of giant knotweed rhizome, 20 to 50 parts of virgate wormwood herb, 25 to 45 parts of bupleurum, 30 to 50 parts of longhairy antenoron herb, 20 to 40 parts of gardenia, 20 to 40 parts of ash bark, 15 to 35 parts of Chinese pulsatilla root, 10 to 30 parts of curcuma aromatica, 10 to 30 parts of yanhusuo, 10 to 30 parts of hawthorn fruit and 5 to 15 parts of common vladimiria root. Experiments prove that the Chinese medicinal preparation (Jinhudankang granules) has the obvious effects of bacteriostasis (in vivo and in vitro) inflammation resistance, analgesia and gallbladder normalizing, and is obviously superior to inflammation diminishing and gallbladder normalizing capsules serving as positive medicines in aspects of bacteriostasis, analgesia and gallbladder normalizing.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation for treating chronic hepatic cholangitis. Background technique [0002] Chronic cholecystitis is a chronic lesion of the gallbladder, most of which are combined with gallstones, and a few are non-gallstone chronic cholecystitis. It is a clinical common disease and frequently-occurring disease. Epidemiological studies have shown that the incidence of cholelithiasis has increased sharply in recent years, and the incidence of this disease is roughly proportional to age. Patients with chronic cholecystitis (cholelithiasis) account for 10% of the total population in the United States, 10%-15% in Germany, 10% in my country, and even up to 15% in middle-aged women [1]. Because primary disease incidence rate is high, complication is many, has a strong impact on people's quality of life. Therefore, the prevention and treatment of chronic cholecystitis (cholelithiasis) is more and more genera...

AI Technical Summary

Problems solved by technology

But from the clinical observation of this kind of medicine, it is found that although there are many Chinese patent medicines on the market at present, some of them have poor curative effect, some of them are outdated in dosage form, and some of them are not easy to accept by patients, and some of them have high prices. Restricted by the age group, it occurs in the old, middle-aged and young people, and the incidence rate is relatively high. Therefore, the number of patients with this disease is large and the demand for drugs is large. The Chinese patent medicines currently on the market for the treatment of capsule inflammation cannot To meet the needs of the market, the development and research of this type of drug has a broad market prospect. This study is guided by the theory of traditional Chinese medicine, based on the long-term clinical experience in the treatment of cholecystitis, and focuses on the main syndromes of damp-heat cholecystitis.

Images